Lipid profiling and transcriptomic analysis reveals a functional interplay between estradiol and growth hormone in liver

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Lipid profiling and transcriptomic analysis reveals a functional interplay between estradiol and growth hormone in liver. / Fernández-Pérez, Leandro; Santana-Farré, Ruymán; Mirecki-Garrido, Mercedes de; García, Irma; Guerra, Borja; Mateo-Diaz, Carlos; Iglesias Gato, Diego; Díaz-Chico, Juan Carlos; Flores Morales, Amilcar; Díaz, Mario.

In: P L o S One, Vol. 9, e96305, 2014.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Fernández-Pérez, L, Santana-Farré, R, Mirecki-Garrido, MD, García, I, Guerra, B, Mateo-Diaz, C, Iglesias Gato, D, Díaz-Chico, JC, Flores Morales, A & Díaz, M 2014, 'Lipid profiling and transcriptomic analysis reveals a functional interplay between estradiol and growth hormone in liver', P L o S One, vol. 9, e96305. https://doi.org/10.1371/journal.pone.0096305

APA

Fernández-Pérez, L., Santana-Farré, R., Mirecki-Garrido, M. D., García, I., Guerra, B., Mateo-Diaz, C., ... Díaz, M. (2014). Lipid profiling and transcriptomic analysis reveals a functional interplay between estradiol and growth hormone in liver. P L o S One, 9, [e96305]. https://doi.org/10.1371/journal.pone.0096305

Vancouver

Fernández-Pérez L, Santana-Farré R, Mirecki-Garrido MD, García I, Guerra B, Mateo-Diaz C et al. Lipid profiling and transcriptomic analysis reveals a functional interplay between estradiol and growth hormone in liver. P L o S One. 2014;9. e96305. https://doi.org/10.1371/journal.pone.0096305

Author

Fernández-Pérez, Leandro ; Santana-Farré, Ruymán ; Mirecki-Garrido, Mercedes de ; García, Irma ; Guerra, Borja ; Mateo-Diaz, Carlos ; Iglesias Gato, Diego ; Díaz-Chico, Juan Carlos ; Flores Morales, Amilcar ; Díaz, Mario. / Lipid profiling and transcriptomic analysis reveals a functional interplay between estradiol and growth hormone in liver. In: P L o S One. 2014 ; Vol. 9.

Bibtex

@article{0fe2477907634ba68cae4c02ec22a04a,
title = "Lipid profiling and transcriptomic analysis reveals a functional interplay between estradiol and growth hormone in liver",
abstract = "17β-estradiol (E2) may interfere with endocrine, metabolic, and gender-differentiated functions in liver in both females and males. Indirect mechanisms play a crucial role because of the E2 influence on the pituitary GH secretion and the GHR-JAK2-STAT5 signaling pathway in the target tissues. E2, through its interaction with the estrogen receptor, exerts direct effects on liver. Hypothyroidism also affects endocrine and metabolic functions of the liver, rendering a metabolic phenotype with features that mimic deficiencies in E2 or GH. In this work, we combined the lipid and transcriptomic analysis to obtain comprehensive information on the molecular mechanisms of E2 effects, alone and in combination with GH, to regulate liver functions in males. We used the adult hypothyroid-orchidectomized rat model to minimize the influence of internal hormones on E2 treatment and to explore its role in male-differentiated functions. E2 influenced genes involved in metabolism of lipids and endo-xenobiotics, and the GH-regulated endocrine, metabolic, immune, and male-specific responses. E2 induced a female-pattern of gene expression and inhibited GH-regulated STAT5b targeted genes. E2 did not prevent the inhibitory effects of GH on urea and amino acid metabolism-related genes. The combination of E2 and GH decreased transcriptional immune responses. E2 decreased the hepatic content of saturated fatty acids and induced a transcriptional program that seems to be mediated by the activation of PPARα. In contrast, GH inhibited fatty acid oxidation. Both E2 and GH replacements reduced hepatic CHO levels and increased the formation of cholesterol esters and triacylglycerols. Notably, the hepatic lipid profiles were endowed with singular fingerprints that may be used to segregate the effects of different hormonal replacements. In summary, we provide in vivo evidence that E2 has a significant impact on lipid content and transcriptome in male liver and that E2 exerts a marked influence on GH physiology, with implications in human therapy.",
author = "Leandro Fern{\'a}ndez-P{\'e}rez and Ruym{\'a}n Santana-Farr{\'e} and Mirecki-Garrido, {Mercedes de} and Irma Garc{\'i}a and Borja Guerra and Carlos Mateo-Diaz and {Iglesias Gato}, Diego and D{\'i}az-Chico, {Juan Carlos} and {Flores Morales}, Amilcar and Mario D{\'i}az",
note = "OA",
year = "2014",
doi = "10.1371/journal.pone.0096305",
language = "English",
volume = "9",
journal = "P L o S One",
issn = "1932-6203",
publisher = "Public Library of Science",

}

RIS

TY - JOUR

T1 - Lipid profiling and transcriptomic analysis reveals a functional interplay between estradiol and growth hormone in liver

AU - Fernández-Pérez, Leandro

AU - Santana-Farré, Ruymán

AU - Mirecki-Garrido, Mercedes de

AU - García, Irma

AU - Guerra, Borja

AU - Mateo-Diaz, Carlos

AU - Iglesias Gato, Diego

AU - Díaz-Chico, Juan Carlos

AU - Flores Morales, Amilcar

AU - Díaz, Mario

N1 - OA

PY - 2014

Y1 - 2014

N2 - 17β-estradiol (E2) may interfere with endocrine, metabolic, and gender-differentiated functions in liver in both females and males. Indirect mechanisms play a crucial role because of the E2 influence on the pituitary GH secretion and the GHR-JAK2-STAT5 signaling pathway in the target tissues. E2, through its interaction with the estrogen receptor, exerts direct effects on liver. Hypothyroidism also affects endocrine and metabolic functions of the liver, rendering a metabolic phenotype with features that mimic deficiencies in E2 or GH. In this work, we combined the lipid and transcriptomic analysis to obtain comprehensive information on the molecular mechanisms of E2 effects, alone and in combination with GH, to regulate liver functions in males. We used the adult hypothyroid-orchidectomized rat model to minimize the influence of internal hormones on E2 treatment and to explore its role in male-differentiated functions. E2 influenced genes involved in metabolism of lipids and endo-xenobiotics, and the GH-regulated endocrine, metabolic, immune, and male-specific responses. E2 induced a female-pattern of gene expression and inhibited GH-regulated STAT5b targeted genes. E2 did not prevent the inhibitory effects of GH on urea and amino acid metabolism-related genes. The combination of E2 and GH decreased transcriptional immune responses. E2 decreased the hepatic content of saturated fatty acids and induced a transcriptional program that seems to be mediated by the activation of PPARα. In contrast, GH inhibited fatty acid oxidation. Both E2 and GH replacements reduced hepatic CHO levels and increased the formation of cholesterol esters and triacylglycerols. Notably, the hepatic lipid profiles were endowed with singular fingerprints that may be used to segregate the effects of different hormonal replacements. In summary, we provide in vivo evidence that E2 has a significant impact on lipid content and transcriptome in male liver and that E2 exerts a marked influence on GH physiology, with implications in human therapy.

AB - 17β-estradiol (E2) may interfere with endocrine, metabolic, and gender-differentiated functions in liver in both females and males. Indirect mechanisms play a crucial role because of the E2 influence on the pituitary GH secretion and the GHR-JAK2-STAT5 signaling pathway in the target tissues. E2, through its interaction with the estrogen receptor, exerts direct effects on liver. Hypothyroidism also affects endocrine and metabolic functions of the liver, rendering a metabolic phenotype with features that mimic deficiencies in E2 or GH. In this work, we combined the lipid and transcriptomic analysis to obtain comprehensive information on the molecular mechanisms of E2 effects, alone and in combination with GH, to regulate liver functions in males. We used the adult hypothyroid-orchidectomized rat model to minimize the influence of internal hormones on E2 treatment and to explore its role in male-differentiated functions. E2 influenced genes involved in metabolism of lipids and endo-xenobiotics, and the GH-regulated endocrine, metabolic, immune, and male-specific responses. E2 induced a female-pattern of gene expression and inhibited GH-regulated STAT5b targeted genes. E2 did not prevent the inhibitory effects of GH on urea and amino acid metabolism-related genes. The combination of E2 and GH decreased transcriptional immune responses. E2 decreased the hepatic content of saturated fatty acids and induced a transcriptional program that seems to be mediated by the activation of PPARα. In contrast, GH inhibited fatty acid oxidation. Both E2 and GH replacements reduced hepatic CHO levels and increased the formation of cholesterol esters and triacylglycerols. Notably, the hepatic lipid profiles were endowed with singular fingerprints that may be used to segregate the effects of different hormonal replacements. In summary, we provide in vivo evidence that E2 has a significant impact on lipid content and transcriptome in male liver and that E2 exerts a marked influence on GH physiology, with implications in human therapy.

U2 - 10.1371/journal.pone.0096305

DO - 10.1371/journal.pone.0096305

M3 - Journal article

VL - 9

JO - P L o S One

JF - P L o S One

SN - 1932-6203

M1 - e96305

ER -

ID: 125635835